D-Dimer as Predictor of Disease Outcome in Intensive Care Unit in COVID-19m Patients

NCT05279469 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 465

Last updated 2022-03-15

No results posted yet for this study

Summary

Evaluating value of D-Dimer blood level of icu admitted patients on admission and 48 hours later as outcome predictor in SARS.COV.2 patients.

Conditions

  • Critical Illness
  • Pneumonia, Viral

Interventions

OTHER

no intervention, just observational for D-Dimer level in blood

observation for basal D-Dimer and 48 hours later D-Dimer in blood for ICU SARS.COV.2 patients

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-10
Primary Completion
2022-03-03
Completion
2022-03-09

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05279469 on ClinicalTrials.gov